FDA’s Drug Shortage Prevention Tally: 96 Saves In Six Weeks
This article was originally published in The Pink Sheet Daily
At Senate hearing, the agency says an executive order has helped spur notifications, while the GAO suggests Congress require manufacturers to tell FDA about anything that could affect the drug supply. Reimbursement changes will not solve the shortage problem, an HHS official argues.
You may also be interested in...
Report says aggressive enforcement in recent years has forced capacity offline, which led to shortages.
Mylan’s Heather Bresch still has questions and House members ask whether it could coexist with mandatory FDA reporting legislation.
Preventing shortages through increased communications with manufacturers could gain the upper hand in part because creating economic incentives may prove too difficult and controversial.